secwatch.observer — SEC 8-K summary
======================================

Issuer:     Adaptive Biotechnologies Corp (ADPT)
CIK:        0001478320
Form:       8-K
Filed at:   2022-01-10T23:59:59+00:00
Accession:  0001564590-22-000785
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adaptive Biotechnologies guides FY2021 revenue $153M-$154M (+56% YoY); CFO Cohen to resign
--------------------------------------------------------------------------------

- FY2021 preliminary revenue $153M-$154M, up ~56% from $98.4M in 2020.
- CFO Chad Cohen resigns effective ~Feb 15, 2022 after 10-K filing; no disagreement.
- Principal Accounting Officer Kyle Piskel to serve as interim CFO; permanent search initiated.
- Preliminary results subject to change; full results expected around Feb 15, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1478320/000156459022000785/0001564590-22-000785-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1478320/000156459022000785/adpt-8k_20220104.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-000785

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer